OnCore BioPharma Inc. Employee Directory
Biotechnology ResearchPennsylvania, United States2-10 Employees
OnCore BioPharma Inc. merged with Tekmira Pharmaceuticals Corp. on March 4, 2015. Effective August 3, 2015, Tekmira Pharmaceuticals Corporation changed its corporate name to Arbutus Biopharma Corporation (“Arbutus”, ticker symbol “ABUS”), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV). The name change affirms the successful integration of OnCore BioPharma and Tekmira Pharmaceuticals into a combined company with the goal of delivering a cure for chronic HBV. For more information please refer to www.arbutusbio.com